Stanford Neurology & Neurological Sciences

Shades of pain: Understanding diversity in pain management

Language and cultural barriers can also limit providers' understanding of how patients are feeling pain, sometimes leading to misdiagnoses of its cause. "If a patient speaks a different language, the way they describe a shooting or burning or stabbing pain might be different from what providers are asking in English, even when using interpreters," said team member Shreya Louis, MD, a neurology resident. "When we as providers base our diagnoses so heavily on the description a patient gives, this language barrier plays a very large role."

Shades of pain: Understanding diversity in pain management Managing pain requires a tailored approach, especially in overcoming cultural and language barriers between a patient and provider.

BE FAST

Can you spot a stroke? BE FAST. Learn what to look for and when to get help: https://stan.md/3l2UrRq

One step back: Why the new Alzheimer's plaque-attack drugs don't work A few closely related drugs, all squarely aimed at treating Alzheimer’s disease, have served up what can be charitably described as a lackadaisical performance. Stanford Medicine neurologist Mike Greicius explains why these drugs, so promising in theory, don’t appear to be helping patients much ...

Since its inception in 2020, Stanford Medicine Catalyst has provided invaluable support for promising health care innovations from Stanford students, faculty, and staff. It was exciting to join the team to mark their latest milestone — a dedicated space at Stanford Research Park — and to celebrate the game-changing ideas that are nurtured through this flagship accelerator. Congratulations to Michael Halaas, Euan Ashley, Kevin Wasserstein, Helen Bronte-Stewart, and the Catalyst team for all they’ve accomplished and all of the achievements ahead.

Did you know that 1 in 5 women suffer from migraines?

Join Dr. Peretz in this Stanford CME conversation. Learn about the 4 phases of migraines, pregnancy & menopause changes & treatment options.

Migraines | Women's Health Series Join us in a conversation with Dr. Addie Peretz, a Clinical Assistant Professor of Neurology & Neurological Sciences at Stanford University. We'll delve into...

Health Matters 2024: Hear from Dr. Longo, a leading expert in the research and treatment of neurological conditions, about the work being done at Stanford to transform the field and offer hope to the millions of people suffering from cognitive impairment due to Alzheimer’s and other neurodegenerative conditions. From novel blood tests and brain imaging approaches to emerging treatments, Dr. Longo will explain the ways he and his fellow scientists are working to detect problems earlier, create strategies to delay onset of cognitive loss, reverse impairment once it begins, and increase brain resiliency for all people. He’ll also offer information you can use, starting now, to help protect your own brain health far into the future.

Health Matters 2024: Brain Power - How Science Is Revolutionizing Cognitive Health We’re living in a neuroscience revolution, with more ways to detect and treat disorders of the brain than was imaginable just a few decades ago. Hear from Dr...

Join TEAM STANFORD at the 2024 San Jose Team Hope 10k Timed Run & 5k Walk scheduled for Saturday, June15th at Campbell Park.

https://ow.ly/gM9M50Sfswj

Speakers include Sharon Sha, MD, Stanford memory disorders specialist; Cameron Dietiker, MD, UCSF movement disorders specialist; Jocelyn Jiao, MD, Stanford neuro-palliative care specialist; Stevy Shadwick, SLP, Kaiser speech therapist; Alexander Dien, DPT and Lucy Lotz, DPT, UCSF physical therapists. In-person or online. Register today!

Progressive Supranuclear Palsy/Corticobasal Degeneration Symposium
June 29, 2024, 10am-3pm PT

This hybrid event is co-hosted by Brain Support Network and Stanford's Movement Disorders Center. Join us online or in-person at Stanford (lunch provided).

Register Today!
In-Person Attendance: bit.ly/june29-oncampus
Online Attendance: bit.ly/june29-on-line

Speakers include Sharon Sha, MD, Stanford memory disorders specialist; Cameron Dietiker, MD, UCSF movement disorders specialist; Jocelyn Jiao, MD, Stanford neuro-palliative care specialist; Stevy Shadwick, SLP, Kaiser speech therapist; Alexander Dien, DPT and Lucy Lotz, DPT, UCSF physical therapists.

We will feature a panel of people coping with PSP/CBD (those with a diagnosis and caregivers), many of whom are members of the Brain Support Network local support groups.

Advance registration required

Help us spread the word by sharing this flyer with your healthcare team, your family, and friends:https://brainsupportnetwork.org/June2024_PSPCBD_RegisterNow.pdf

Stanford Medicine celebrates and recognizes the LGBTQ community's invaluable contributions toward the field of medicine. https://stan.md/3OtRs3o

About Corticobasal Degeneration (CBD)

Corticobasal Degeneration (CBD) is the rarest of the four atypical parkinsonism disorders. Depending on whom you ask, it’s classified as an atypical parkinsonism disorder, a non-Alzheimer’s dementia, or a type of frontotemporal degeneration. CBD is most closely similar to PSP in terms of symptoms and pathology. Many organizations that perform research on PSP also research CBD.

Because CBD is so rare, research has been very limited. Most studies of autopsy-confirmed disease only include a few dozen cases. It’s hard to be definitive with such small numbers.

The medical community now uses the term CBS or corticobasal syndrome to refer to a clinical diagnosis. CBD or corticobasal degeneration is now used for an autopsy-confirmed diagnosis.

Learn more about symptoms, treatments, and resources here: https://www.brainsupportnetwork.org/education/corticobasal-degeneration/

Join us at our upcoming PSP/CBD Symposium
Co-hosted with Stanford's Movement Disorders Center:
June 29, 2024 • 10 - 3pm
Online: http://bit.ly/june29-on-line
In-Person: http://bit.ly/june29-oncampus

Myelination in the brain may be key to ‘learning’ opioid addiction New research in mice by Stanford Medicine scientists has found that the process of adaptive myelination, which helps the brain learn new skills, can also promote addiction to opioids.

About Progressive Supranuclear Palsy (PSP)

PSP is the second most common of the four atypical parkinsonism disorders. It is a rare disease. Depending on who you ask, PSP is classified as an atypical parkinsonism disorder, a non-Alzheimer’s dementia, and a type of frontotemporal degeneration.

PSP exists in two main variants: Richardson’s syndrome (PSP-RS) and PSP-parkinsonism (PSP-P). For the PSP-RS variant, primary symptoms are falls (usually backwards), dysarthria (slurred speech), and cognitive impairment. For the PSP-P variant, primary symptoms are tremor and a response to levodopa. For both variants, symptoms include bradykinesia (slow movement), and rigidity (stiffness)…in other words, parkinsonism.

Learn more about symptoms, treatments, and resources here: https://www.brainsupportnetwork.org/education/progressive-supranuclear-palsy/

And join us at our upcoming PSP/CBD Symposium, co-hosted with Stanford's Movement Disorders Center:

Save The Date - PSP/CBD Symposium
June 29, 2024 • 10 - 3pm
Online or In-Person

Stanford Neurology shined 🤩 at the 4th annual Stanford Medicine Pride Parade!! Celebrating love and diversity and honoring LGBTQIA+ contributions within our team and across the School of Medicine. 🌈🧠💕

Stanford Brain Tumor Center and Stanford Medicine Children's Health are participating in the Northern California Brain Tumor Walk & Race on Saturday, June 8, 2024 at the San Francisco Zoo. Join our team and/or donate: https://secure.braintumor.org/site/TR/TeamraiserEvents/BayAreaBrainTumorWalk?px=3959889&pg=personal&fr_id=3859

Listen to Dr. Frank Longo of Stanford University speak about the work being done at Stanford to transform the field & offer hope to the millions of people suffering from cognitive impairment due to Alzheimer’s & other neurodegenerative conditions

Health Matters 2024: Brain Power - How Science Is Revolutionizing Cognitive Health We’re living in a neuroscience revolution, with more ways to detect and treat disorders of the brain than was imaginable just a few decades ago. Hear from Dr...

Join us in a conversation with Dr. Addie Peretz, a Clinical Assistant Professor of Neurology & Neurological Sciences at Stanford University. We'll delve into the issue of migraines, affecting 1 in 5 women. Our discussion will include the four phases of migraines, the changes during pregnancy and menopause, and an array of treatment options for this debilitating condition. We'll provide insights on preventing migraines, managing lifestyle factors, and utilizing complementary approaches.

Migraines | Women's Health Series Join us in a conversation with Dr. Addie Peretz, a Clinical Assistant Professor of Neurology & Neurological Sciences at Stanford University. We'll delve into...

Despite the rainy weather, the Stanford Multiple Sclerosis and Neuroimmunology Program participated in Walk MS: Silicon Valley 2024. Walk MS brings together passionate people for a powerful purpose: to end MS forever. https://events.nationalmssociety.org/team/60764

Can you spot a stroke? BE FAST. Learn what to look for and when to get help: https://stan.md/3l2UrRq

From loss comes hope: Pediatric brain tumor treatment shows promise Research from early clinical trials of pediatric glioma patients shows that altered immune cells can fight the deadly brainstem tumor.

The Stanford University School of Medicine 11th Annual Neuroscience Forum was held today. The Annual Neuroscience Forum is an event that highlights research accomplishments of Residents, Fellows, Medical Students and Post-Graduates in Neurosciences.

https://med.stanford.edu/neurosurgery/events/neuroscience-forum.html

Thank you to everyone who joined the Team in our fight to beat Parkinson's Disease at the Parkinson's San Jose! Your support means the world to us.

https://secure3.convio.net/prkorg/site/TR/MovingDayEvent/General?team_id=73728&pg=team&fr_id=4996

A new test can detect the biological signature of Parkinson’s disease before symptoms arise. Stanford Medicine neurologist, Kathleen Poston, MD, MS, explains why early diagnosis opens the door to better therapies.

Game-changing Parkinson’s biomarker could speed up clinical trials for treatment | 90 Seconds A new test can detect the biological signature of Parkinson’s disease before symptoms arise. Stanford Medicine neurologist, Kathleen Poston, MD, MS, explains...

LIVING WITH EPILEPSY CONFERENCE. May 11, 2024. Don't miss this opportunity to learn, connect, and empower yourself or your loved ones living with epilepsy. Together, we can navigate this journey with knowledge and resilience. https://epilepsynorcal.org/events/lwe2024may/

Our Neurocritical Care, Stroke & Neurohospitalist groups recently had a great night at a Thai cooking class. They made spring rolls, satay skewers, and pad Thai! Yum!!

MSA Symposium
May 4, 2024 • 10am – 3pm PST
Register Today: bit.ly/msa-symposium

Speakers Spotlight:
Elena Call, MD, Kaiser Movement Disorders Specialist
Stanford University School of Medicine graduate, residency in Adult Neurology in 2016 and fellowship in Movement Disorders in 2017, both at Stanford University Medical Center. Dr Call sees patients with general neurological conditions and specialize in the care of a variety of movement disorders including Parkinson’s disease, atypical forms of parkinsonism, essential tremor, dystonia, Huntington’s disease, chorea, myoclonus, and functional movement disorders. Dr Call also helps care for patients who have undergone deep brain stimulation (DBS) surgery.

Stevy Shadwick, SLP, Kaiser Speech Therapist
Dr Shadwich provides Speech Pathology care for both pediatric and adult populations. Diagnosing and treating a variety of communication, and swallowing disorders, working with our regions Head and Neck cancer team, Dr Shadwick specialties include AAC/speech generating devices, voice and upper airway disorders, and differential diagnosis and management of neurological disorders with an interdisciplinary team.

Everyone is welcome—those with MSA, caregivers, family members, healthcare professionals, and anyone in the community wanting to learn more about this rare atypical parkinsonism disorder.

In-person and online
In-person at Stanford: Doors open 9:30am - Lunch provided
Space is limited